Accelerate Diagnostics Performance
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Accelerate Diagnostics are completely uncorrelated. Accelerate Diagnostics right now shows a risk of 0.0%. Please confirm Accelerate Diagnostics accumulation distribution , to decide if Accelerate Diagnostics will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Accelerate Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Accelerate Diagnostics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Accelerate |
Accelerate Diagnostics Relative Risk vs. Return Landscape
If you would invest (100.00) in Accelerate Diagnostics on October 3, 2025 and sell it today you would earn a total of 100.00 from holding Accelerate Diagnostics or generate -100.0% return on investment over 90 days. Accelerate Diagnostics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Accelerate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Accelerate Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Accelerate Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Accelerate Diagnostics, and traders can use it to determine the average amount a Accelerate Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AXDX |
Based on monthly moving average Accelerate Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Accelerate Diagnostics by adding Accelerate Diagnostics to a well-diversified portfolio.
Accelerate Diagnostics Fundamentals Growth
Accelerate Stock prices reflect investors' perceptions of the future prospects and financial health of Accelerate Diagnostics, and Accelerate Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Accelerate Stock performance.
| Return On Asset | -0.74 | |||
| Operating Margin | (2.82) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 25.29 M | |||
| Price To Earning | (15.18) X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 11.7 M | |||
| EBITDA | (33.57 M) | |||
| Cash And Equivalents | 36.77 M | |||
| Cash Per Share | 0.45 X | |||
| Total Debt | 66.58 M | |||
| Debt To Equity | 2.76 % | |||
| Book Value Per Share | (2.23) X | |||
| Cash Flow From Operations | (24.19 M) | |||
| Earnings Per Share | (2.15) X | |||
| Total Asset | 28.56 M | |||
| Retained Earnings | (718.9 M) | |||
| Current Asset | 91.68 M | |||
| Current Liabilities | 4.45 M | |||
About Accelerate Diagnostics Performance
Evaluating Accelerate Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Accelerate Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Accelerate Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. Accelerate Diagnosti operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 220 people.Things to note about Accelerate Diagnostics performance evaluation
Checking the ongoing alerts about Accelerate Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Accelerate Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Accelerate Diagnostics is not yet fully synchronised with the market data | |
| Accelerate Diagnostics has some characteristics of a very speculative penny stock | |
| Accelerate Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 11.7 M. Net Loss for the year was (50.05 M) with profit before overhead, payroll, taxes, and interest of 2.7 M. | |
| Accelerate Diagnostics currently holds about 36.77 M in cash with (24.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company shares are held by company insiders |
- Analyzing Accelerate Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Accelerate Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Accelerate Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Accelerate Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Accelerate Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Accelerate Diagnostics' stock. These opinions can provide insight into Accelerate Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |